Suzhou Zelgen Biopharmaceuticals Co., Ltd. (688266.SS)
CNY 105.94
(2.03%)
CNY 105.94
(2.03%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -220.31 Million | -370.34 Million | -454.62 Million | -343.85 Million | -180.42 Million | -112.43 Million |
| Net Income | -278.58 Million | -485.94 Million | -461.99 Million | -310.67 Million | -447.98 Million | -441.87 Million |
| Depreciation & Amortization | 60.4 Million | 66.36 Million | 50.77 Million | 34.71 Million | 33 Million | 13.84 Million |
| Deferred income taxes | -3.73 Million | -2.44 Million | -3.63 Million | -4.08 Million | -4.34 Million | -780.4 Thousand |
| Stock-based compensation | -34.1 Million | 37.06 Million | 34.62 Million | 31.11 Million | 237.44 Million | 309.05 Million |
| Change in working capital | 28.26 Million | 218.81 Thousand | -77.6 Million | -88.34 Million | -3.06 Million | 14.82 Million |
| Other non-cash items | 65.88 Million | 14.39 Million | 3.2 Million | -6.59 Million | 4.51 Million | 300.76 Million |
| Investing Cash Flow | 52.4 Million | -264.05 Million | 326.65 Million | -499.25 Million | 63.32 Million | -53.11 Million |
| Investments in PPE | -62.6 Million | -88.62 Million | -70.73 Million | -57.68 Million | -15.1 Million | -11.08 Million |
| Acquisitions | 2600.00 | -24.22 Million | -8.35 Million | 57.68 Million | 15.1 Million | -15.45 Million |
| Investment purchases | -1.13 Billion | -943.09 Million | -520 Million | -1.13 Billion | -195 Million | -344.9 Million |
| Sales/Maturities of investments | 1.25 Billion | 767.66 Million | 917.39 Million | 693.43 Million | 273.43 Million | 317.59 Million |
| Other Investing Activities | 127.44 Million | 24.22 Million | 8.35 Million | -57.68 Million | -15.1 Million | 728.54 Thousand |
| Financing Cash Flow | 1.5 Billion | 282.79 Million | 93.99 Million | 1.89 Billion | 54.31 Million | 285.37 Million |
| Debt repayment | -353.8 Million | -232.6 Million | -57.45 Million | -12.35 Million | -20 Million | - |
| Dividends payments | -21.17 Million | -11.21 Million | -4.14 Million | -1.11 Million | -1.15 Million | - |
| Common Stock Repurchased | - | - | - | - | 4.54 Million | - |
| Common Stock Issuance | -1.44 Million | - | - | -113.1 Million | -4.54 Million | - |
| Other Financing Activities | 1.17 Billion | 526.6 Million | 155.58 Million | 1.91 Billion | 75.47 Million | 285.37 Million |
| Accounts receivables | -38.35 Million | -17.41 Million | -84.19 Million | -20.87 Million | -11 Million | -3.86 Million |
| Accounts payables | 78.49 Million | 67.14 Million | 38.99 Million | -46.68 Million | 16.16 Million | 21.54 Million |
| Inventory | -11.87 Million | -47.06 Million | -28.77 Million | -16.71 Million | -3.87 Million | -2.07 Million |
| Other working capital | -34.1 Million | -2.44 Million | -3.63 Million | -4.08 Million | -4.34 Million | 16.9 Million |
| Cash at beginning of period | 797.04 Million | 1.08 Billion | 1.11 Billion | 66.92 Million | 128.93 Million | 9.88 Million |
| Cash at end of period | 2.1 Billion | 736.1 Million | 1.08 Billion | 1.11 Billion | 66.92 Million | 128.93 Million |
| Capital Expenditure | -62.6 Million | -88.62 Million | -70.73 Million | -57.68 Million | -15.1 Million | -11.08 Million |
| Effect of forex changes on cash | 216.71 Thousand | 4.06 Million | -1.43 Million | -3.79 Million | 768.52 Thousand | -776.76 Thousand |
| Net cash flow / Change in cash | 1.31 Billion | -347.53 Million | -35.4 Million | 1.05 Billion | -62.01 Million | 119.04 Million |
| Free Cash Flow | -282.91 Million | -458.96 Million | -525.36 Million | -401.53 Million | -195.53 Million | -123.51 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -31.36 Million | -27.03 Million | -39.49 Million | -76.49 Million | -278.58 Million | -87.86 Million |
| Depreciation & Amortization | - | 13.98 Million | 13.98 Million | 14.42 Million | 60.4 Million | -28.69 Million |
| Deferred income taxes | - | - | - | -3.73 Million | -3.73 Million | 1.95 Million |
| Stock-based compensation | - | 732.78 Thousand | - | -34.1 Million | -34.1 Million | 17.28 Million |
| Change in working capital | - | -59.46 Million | - | -84.33 Million | 28.26 Million | 32.93 Million |
| Other non-cash items | -14.02 Million | 68.47 Million | 128.75 Million | 98.2 Million | 65.88 Million | -31.1 Million |
| Investing Cash Flow | -27.13 Million | 347.55 Million | -316.13 Million | 140.21 Million | 52.4 Million | 341.46 Million |
| Investments in PPE | -14.73 Million | -20.45 Million | -30.22 Million | -19.78 Million | -62.6 Million | -11.71 Million |
| Acquisitions | - | - | - | -167.07 Million | 2600.00 | - |
| Investment purchases | -230 Million | -310 Million | -403 Million | -435 Million | -1.13 Billion | - |
| Sales/Maturities of investments | 217.6 Million | 678 Million | 117.09 Million | 595 Million | 1.25 Billion | 353.17 Million |
| Other Investing Activities | - | 371.93 Million | -285.67 Million | 167.07 Million | 127.44 Million | 0.27 |
| Financing Cash Flow | -122.49 Million | -50.24 Million | 94.61 Million | 29.64 Million | 1.5 Billion | 92.45 Million |
| Debt repayment | -31.9 Million | -39.9 Million | -107 Million | -35.9 Million | -353.8 Million | -237 Million |
| Dividends payments | -5.93 Million | -6.54 Million | -6.22 Million | -5.77 Million | -21.17 Million | -5.76 Million |
| Common Stock Repurchased | - | - | - | - | - | -1.25 Million |
| Common Stock Issuance | - | - | - | -1.44 Million | -1.44 Million | 1.25 Million |
| Other Financing Activities | -84.65 Million | -383.26 Thousand | -12.38 Million | 9.37 Million | 1.17 Billion | 335.21 Million |
| Accounts receivables | - | -29.92 Million | - | -38.35 Million | -38.35 Million | 20.86 Million |
| Accounts payables | - | - | - | - | 78.49 Million | -17.28 Million |
| Inventory | - | -30.27 Million | - | -11.87 Million | -11.87 Million | 12.06 Million |
| Other working capital | - | 732.78 Thousand | - | -34.1 Million | -34.1 Million | 17.28 Million |
| Cash at beginning of period | 2.27 Billion | 1.98 Billion | 2.1 Billion | 1.92 Billion | 797.04 Million | 1.56 Billion |
| Cash at end of period | 2.07 Billion | 2.32 Billion | 1.98 Billion | 2.1 Billion | 2.1 Billion | 1.9 Billion |
| Capital Expenditure | -14.73 Million | -20.45 Million | -30.22 Million | -19.78 Million | -62.6 Million | -11.71 Million |
| Effect of forex changes on cash | -573.75 Thousand | 26.22 Thousand | 10.79 Thousand | -95.4 Thousand | 216.71 Thousand | -102.76 Thousand |
| Net cash flow / Change in cash | -196.1 Million | 331.14 Million | -120.51 Million | 184.04 Million | 1.31 Billion | 338.31 Million |
| Free Cash Flow | -60.13 Million | 7.01 Million | 59.02 Million | -16.24 Million | -282.91 Million | -107.21 Million |
8176
WSPCF
SIGNPOST
FUJIY
C76
NOW